Patents by Inventor Jonine Figueroa

Jonine Figueroa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PLASMA AUTOANTIBODY BIOMARKERS FOR BASAL LIKE BREAST CANCER
    Publication number: 20230079737
    Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
    Type: Application
    Filed: September 8, 2022
    Publication date: March 16, 2023
    Inventors: Joshua LaBaer, Jie Wang, Ji Qiu, Garrick Wallstrom, Karen Anderson, Jin Park, Jonine Figueroa
  • Plasma autoantibody biomarkers for basal like breast cancer
    Patent number: 11525831
    Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
    Type: Grant
    Filed: January 15, 2020
    Date of Patent: December 13, 2022
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Joshua LaBaer, Jie Wang, Ji Qui, Garrick Wallstrom, Karen Anderson, Jin Park, Jonine Figueroa
  • PLASMA AUTOANTIBODY BIOMARKERS FOR BASAL LIKE BREAST CANCER
    Publication number: 20200182874
    Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
    Type: Application
    Filed: January 15, 2020
    Publication date: June 11, 2020
    Inventors: Joshua LaBaer, Jie Wang, Ji Qui, Garrick Wallstrom, Karen Anderson, Jin Park, Jonine Figueroa
  • PLASMA AUTOANTIBODY BIOMARKERS FOR BASAL LIKE BREAST CANCER
    Publication number: 20170363631
    Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
    Type: Application
    Filed: December 9, 2015
    Publication date: December 21, 2017
    Inventors: Joshua LaBaer, Jie Wang, Ji Qiu, Garrick Wallstrom, Karen Anderson, Jin Park, Jonine Figueroa